Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Insmed Inc shares valued at $5,996,094 were sold by Bonstein Sara on Jul 21 ’25. At $102.67 per share, Bonstein Sara sold 58,400 shares. The insider’s holdings dropped to 73,505 shares worth approximately $7.73 million following the completion of this transaction.
Also, Bonstein Sara purchased 58,400 shares, netting a total of over 5,994,443 in proceeds.
Before that, Lewis William had sold 6,830 shares from its account. In a trade valued at $699,220, the Chair and CEO traded Insmed Inc shares for $102.37 each. Upon closing the transaction, the insider’s holdings decreased to 6,830 shares, worth approximately $24.6 million.
As published in their initiating research note from Jefferies on May 13, 2025, Insmed Inc [INSM] has been a Buy and the price target has been revised to $105. Analysts at RBC Capital Mkts started covering the stock with ‘”an Outperform”‘ outlook in a report released in late February. As of April 23, 2024, Truist has initiated its “Buy” rating for INSM. Earlier on February 15, 2024, Wolfe Research initiated its rating. Their recommendation was “an Outperform” for INSM stock.
Analyzing INSM Stock Performance
On last trading session,, Insmed Inc [NASDAQ: INSM] rose 0.17% to $105.18. The stock’s lowest price that day was $103.5, but it reached a high of $107.41 in the same session. During the last five days, there has been a surge of approximately 1.68%. Over the course of the year, Insmed Inc shares have jumped approximately 41.11%.
Support And Resistance Levels for Insmed Inc (INSM)
RSI (Relative Strength Index) is 65.68 on the 14-day chart, showing neutral technical sentiment.
Is Insmed Inc subject to short interest?
Stocks of Insmed Inc saw a sharp steep in short interest on 2025-07-15 dropping by -1.96 million shares to 9.69 million. Data from Yahoo Finance shows that the short interest on 2025-06-13 was 11.65 million shares. A decline of -20.25% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 2.0 of the overall float, the days-to-cover ratio (short ratio) decline to 2.0.
Which companies own the most shares of Insmed Inc (INSM)?
In terms of Insmed Inc share price expectations, FactSet research, analysts set an average price target of 110 in the next 12 months, up nearly 4.76% from the previous closing price of $105.0. Analysts anticipate Insmed Inc stock to reach 110 by 2025, with the lowest price target being 110. In spite of this, 14 analysts ranked Insmed Inc stock as Buy at the end of 2025. On December 08, 2023, Wells Fargo assigned a price target of “an Overweight” to the stock and initiated coverage with a $55.
